J. Freeman, MD, “FDA approves Alzheimer’s drug against the recommendation of its scientific panel. Be very concerned”., rrnmf, vol. 2, no. 5, pp. 5–6, Dec. 2021, doi: 10.17161/rrnmf.v2i5.15979.